Crossmark Global Holdings’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.79M Sell
54,209
-419
-0.8% -$29.3K 0.06% 291
2025
Q1
$4.02M Buy
54,628
+1,507
+3% +$111K 0.07% 273
2024
Q4
$3.48M Sell
53,121
-317
-0.6% -$20.8K 0.06% 291
2024
Q3
$4.16M Buy
53,438
+12,956
+32% +$1.01M 0.07% 267
2024
Q2
$3.16M Buy
40,482
+1,303
+3% +$102K 0.06% 302
2024
Q1
$2.65M Sell
39,179
-1,315
-3% -$89.1K 0.05% 348
2023
Q4
$2.73M Buy
40,494
+949
+2% +$63.9K 0.06% 331
2023
Q3
$2.69M Buy
39,545
+48
+0.1% +$3.26K 0.06% 315
2023
Q2
$2.82M Buy
39,497
+1,709
+5% +$122K 0.06% 327
2023
Q1
$2.62M Buy
37,788
+239
+0.6% +$16.6K 0.06% 334
2022
Q4
$2.55M Sell
37,549
-552
-1% -$37.4K 0.06% 331
2022
Q3
$2.09M Buy
38,101
+5,251
+16% +$288K 0.06% 341
2022
Q2
$2.17M Sell
32,850
-1,790
-5% -$118K 0.06% 356
2022
Q1
$2.3M Buy
34,640
+2,940
+9% +$195K 0.05% 373
2021
Q4
$1.85M Hold
31,700
0.04% 438
2021
Q3
$1.9M Buy
31,700
+5,550
+21% +$333K 0.04% 398
2021
Q2
$1.57M Sell
26,150
-1,660
-6% -$99.4K 0.04% 468
2021
Q1
$1.38M Sell
27,810
-11,615
-29% -$578K 0.03% 490
2020
Q4
$1.97M Sell
39,425
-7,718
-16% -$386K 0.05% 377
2020
Q3
$2.58M Buy
47,143
+1,320
+3% +$72.3K 0.07% 281
2020
Q2
$2.42M Sell
45,823
-1,885
-4% -$99.7K 0.07% 293
2020
Q1
$2.13M Buy
47,708
+2,260
+5% +$101K 0.08% 274
2019
Q4
$2.27M Buy
45,448
+2,190
+5% +$109K 0.06% 331
2019
Q3
$1.93M Sell
43,258
-20,790
-32% -$927K 0.06% 365
2019
Q2
$2.64M Buy
64,048
+2,710
+4% +$112K 0.07% 303
2019
Q1
$2.48M Buy
61,338
+1,000
+2% +$40.4K 0.07% 312
2018
Q4
$2.29M Sell
60,338
-770
-1% -$29.2K 0.07% 309
2018
Q3
$2.42M Buy
61,108
+24,369
+66% +$964K 0.06% 350
2018
Q2
$1.29M Sell
36,739
-59,860
-62% -$2.1M 0.03% 513
2018
Q1
$3.38M Sell
96,599
-25,402
-21% -$888K 0.09% 281
2017
Q4
$4.23M Sell
122,001
-540
-0.4% -$18.7K 0.1% 241
2017
Q3
$4.15M Buy
+122,541
New +$4.15M 0.11% 230
2016
Q3
$4.15M Buy
+122,541
New +$4.15M 0.11% 230